Black Patients Less Likely to Get Into Pancreatic Cancer Clinical Trials
WEDNESDAY, April 13, 2022 (HealthDay News) — Black Americans are far less likely to be included in clinical trials of pancreatic cancer drugs than white Americans, and eligibility criteria are a significant factor in that gap, according to a new study. “The standard of care in cancer treatment is informedContinue Reading